Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.
The phosphoinositide 3-kinase (PI3K) family has multiple vascular functions, but the specific regulatory isoform supporting lymphangiogenesis remains unidentified. Here, we report that deletion of the Pik3r1 gene, encoding the regulatory subunits p85alpha, p55alpha, and p50alpha impairs lymphatic sprouting and maturation, and causes abnormal lymphatic morphology, without major impact on blood vessels. Pik3r1 deletion had the most severe consequences among gut and diaphragm lymphatics, which share the retroperitoneal anlage, initially suggesting that the Pik3r1 role in this vasculature is anlage-dependent. However, whereas lymphatic sprouting toward the diaphragm was arrested, lymphatics invaded the gut, where remodeling and valve formation were impaired. Thus, cell-origin fails to explain the phenotype. Only the gut showed lymphangiectasia, lymphatic up-regulation of the transforming growth factor-beta co-receptor endoglin, and reduced levels of mature vascular endothelial growth factor-C protein. Our data suggest that Pik3r1 isoforms are required for distinct steps of embryonic lymphangiogenesis in different organ microenvironments, whereas they are largely dispensable for hemangiogenesis.
Mouta-Bellum
Carla
C
Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine, USA.
Kirov
Aleksander
A
Miceli-Libby
Laura
L
Mancini
Maria L
ML
Petrova
Tatiana V
TV
Liaw
Lucy
L
Prudovsky
Igor
I
Thorpe
Philip E
PE
Miura
Naoyuki
N
Cantley
Lewis C
LC
Alitalo
Kari
K
Fruman
David A
DA
Vary
Calvin P H
CP
D000818:Animals; D000831:Animals, Newborn / Q000033:anatomy & histology / Q000502:physiology; D018390:Gene Targeting; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D008200:Lymphangiectasis / Q000473:pathology / Q000503:physiopathology; D042583:Lymphangiogenesis / Q000502:physiology*; D042601:Lymphatic Vessels / Q000002:abnormalities / Q000033:anatomy & histology / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism; D021122:Protein Subunits / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
D007527:Isoenzymes; D021122:Protein Subunits; D019869:Phosphatidylinositol 3-Kinases
Dev Dyn. 2007 Jul;236(7):2020-5
17576138
Int J Dev Biol. 2005;49(2-3):355-61
15906251
Science. 1999 Jan 15;283(5400):393-7
9888855
Cell. 2007 Jun 1;129(5):957-68
17540175
Nat Med. 2004 Sep;10(9):974-81
15322537
J Biol Chem. 2004 Jun 25;279(26):27088-97
15102829
Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2546-52
11116051
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):419-24
11752399
Nat Genet. 2000 Nov;26(3):379-82
11062485
Dev Biol. 2007 Aug 15;308(2):520-33
17628518
Dev Cell. 2002 Sep;3(3):411-23
12361603
Blood. 2008 May 1;111(9):4571-9
18310502
Cancer Treat Res. 2004;117:3-32
15015550
Am J Pathol. 1998 Aug;153(2):395-403
9708800
Blood. 1998 Dec 15;92(12):4677-90
9845534
Z Zellforsch Mikrosk Anat. 1962;57:475-86
13941327
J Cell Biol. 1996 Jun;133(5):1109-21
8655583
APMIS. 1994 Sep;102(9):647-61
7946268
Atherosclerosis. 2000 Dec;153(2):323-35
11164421
J Pathol. 2006 May;209(1):67-77
16482496
Trends Immunol. 2004 Jul;25(7):387-95
15207507
Hum Mol Genet. 1999 Nov;8(12):2171-81
10545596
Genes Dev. 2005 Feb 1;19(3):397-410
15687262
Recent Prog Horm Res. 2004;59:51-71
14749497
Anat Embryol (Berl). 2001 Nov;204(5):399-406
11789987
Mol Cell Biol. 2004 Jan;24(1):320-9
14673165
Nat Genet. 1994 Dec;8(4):345-51
7894484
Blood. 2007 Apr 1;109(7):2894-902
17164340
J Exp Med. 2009 May 11;206(5):1089-102
19398755
Oncogene. 2008 Sep 18;27(41):5511-26
18794885
J Cell Physiol. 2005 Aug;204(2):574-84
15702480
Cancer Res. 2003 Mar 15;63(6):1166-71
12649170
Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):294-300
14656735
Curr Opin Pharmacol. 2005 Aug;5(4):357-65
15963759
Circulation. 1997 Dec 16;96(12):4333-42
9416901
Immunol Rev. 2009 Mar;228(1):253-72
19290933
Mol Endocrinol. 2002 Apr;16(4):873-83
11923482
J Cell Biochem. 2007 Dec 15;102(6):1375-88
17975795
Nat Immunol. 2004 Jan;5(1):74-80
14634646
Nat Rev Immunol. 2004 Jan;4(1):35-45
14704766
Blood. 2002 Dec 1;100(12):4001-10
12433697
EMBO J. 2001 Sep 3;20(17):4762-73
11532940
Nat Rev Genet. 2006 Aug;7(8):606-19
16847462
Cell Tissue Res. 2003 Oct;314(1):69-84
12942362